Life Senate Democrats Lay Out Plans to Overhaul Health Insurance After Setbacks Under Trump Democrats are sharpening their health care message as the midterms loom. Editorial Staff Mar 19
Life Briefing: Eli Lilly’s ‘triple-G’ shows potency, raises concerns Strategic angle: Eli Lilly's 'triple-G' drug shows potency, In-vivo CAR-T inches toward clinical reality, and more in today's Readout newsletter. Editorial Staff Mar 19
Life Briefing: STAT+: A biotech turns to Apple Watch to study its Parkinson’s drug Strategic angle: In this edition of STAT Health Tech: How Apple Watch is being used in a clinical trial for a Parkinson's drug, and more Editorial Staff Mar 19
Life Two doctors on the challenges of medicine today In today's Morning Rounds newsletter, a Texas couple getting rich off out-of-network medical bills, two doctors on the challenges of medicine today, and more. Editorial Staff Mar 19
Life Briefing: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial Strategic angle: Diabetes patients taking an investigational drug from Eli Lilly saw significant reductions in their blood sugar and weight in a late-stage study. Editorial Staff Mar 19
Life Briefing: STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure? Editorial Staff Mar 19
Life Cost Concerns and Coverage Changes: A Follow-Up Survey of ACA Marketplace Enrollees This KFF survey examines the cost concerns and coverage changes experienced by ACA Marketplace enrollees in 2025 following the expiration of enhanced benefits. Editorial Staff Mar 19
Life Briefing: HHS Watchdog Critiques Nursing Homes for Antipsychotic Drug Misuse Strategic angle: Nursing homes misuse antipsychotic drugs for dementia patients, disguising the practice as schizophrenia treatment, a watchdog finds. Editorial Staff Mar 19
Life Briefing: FDA’s top infectious disease regulator to depart agency Strategic angle: Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency. Editorial Staff Mar 18
Life Briefing: More than 150,000 uncounted Covid-19 deaths occurred early in the pandemic, a study finds Strategic angle: The Covid-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that spotlights dramatic disparities in the uncounted deaths. Editorial Staff Mar 18
Life Briefing: Maryland Legislator Proposes Bill for Pharma Transparency in Disease Awareness Campaigns Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives. Editorial Staff Mar 18
Life Briefing: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy Strategic angle: A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access. Editorial Staff Mar 18
Life Briefing: STAT+: How ARPA-H is developing FDA-authorized AI agents, tested in clinical trials Strategic angle: STAT's AI Prognosis takes a closer look at how the U.S. moonshot agency for health research is developing AI agents for deployment in hospitals. Editorial Staff Mar 18
Life Briefing: A Huntington’s researcher on the UniQure-FDA fray Strategic angle: A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter. Editorial Staff Mar 18
Life Briefing: Premature menopause is linked to 40% increase in heart disease risk Strategic angle: JAMA Cardiology study highlights the increased heart disease risk associated with premature menopause, particularly among Black women. Editorial Staff Mar 18
Life Briefing: As Trump administration cracks down on health care fraud, people with disabilities feel singled out Strategic angle: As the Trump administration goes after fraud in health care, advocates say the disability community feels singled out. Editorial Staff Mar 18
Life Briefing: STAT+: Pharmalittle: We’re reading about TrumpRx prices, a J&J psoriasis pill, and much more Strategic angle: U.S. health officials claim TrumpRx offers Americans the world’s lowest prices on prescription drugs, but a new analysis found that is not true. Editorial Staff Mar 18
Life Briefing: FDA and NIH announce more initiatives to reduce animal testing in drug development Strategic angle: The HHS has made reducing animal testing a priority over the past year. Editorial Staff Mar 18
Life Briefing: Quiz – How Well Do You Understand Your Health Insurance – Frameless Strategic angle: Test your knowledge on health insurance with this 10-question quiz to make informed decisions about your coverage. Editorial Staff Mar 18
Life Briefing: J&J Wins Approval for First-of-its-Kind Psoriasis Pill Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market. Editorial Staff Mar 18